Estimation of the time of pulmonary metastasis in colorectal cancer patients with isolated synchronous liver metastasis

Japanese Journal of Clinical Oncology

Volumn 35, Issue 1, 2005, Pages 18-22

  Sadahiro, Sotaro ^a   Suzuki, Toshiyuki ^a   Ishikawa, Kenji ^a   Nakamura, Tomoki ^a   Tanaka, Yoichi ^a   Ishizu, Kazuhiro ^a   Yasuda, Seiei ^a   Makuuchi, Hiroyasu ^a   Murayama, Chieko ^a  

^a TOKAI UNIVERSITY   (Japan)

Author keywords

Colorectal cancer; Liver metastasis; Pulmonary metastasis; Tumor doubling time

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROPYRIMIDINE; FLUOROURACIL; ANTINEOPLASTIC ANTIMETABOLITE;

ARTICLE; CANCER REGRESSION; COLORECTAL CANCER; COLORECTAL SURGERY; CONTROLLED STUDY; DRUG INFUSION; HEPATIC ARTERY; HUMAN; INOPERABLE CANCER; LIVER METASTASIS; LIVER RESECTION; LUNG METASTASIS; MAJOR CLINICAL STUDY; OCCULT CANCER; THORAX RADIOGRAPHY; TIME; TUMOR GROWTH; CELL DIVISION; COLORECTAL TUMOR; INTRAARTERIAL DRUG ADMINISTRATION; LIVER TUMOR; LUNG TUMOR; METASTASIS; MULTIPLE CANCER; PATHOLOGY; PHYSIOLOGY; RETROSPECTIVE STUDY;

ANTIMETABOLITES, ANTINEOPLASTIC; CELL DIVISION; COLORECTAL NEOPLASMS; FLUOROURACIL; HEPATECTOMY; HEPATIC ARTERY; HUMANS; INFUSIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; LUNG NEOPLASMS; NEOPLASMS, MULTIPLE PRIMARY; RETROSPECTIVE STUDIES; TIME;

EID: 14944381896     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/hyi010     Document Type: Article

References (32)

1. Galandiuk S, Wieand HS, Moertel CG, Cha SS, Fitzgibbons RJ Jr, Pemberton JH et al. Patterns of recurrence after curative resection of carcinoma of the colon and rectum. Surg Gynecol Obstet 1992;174:27-32.
2. Tominaga T, Sakabe T, Koyama Y, Hamano K, Yasutomi M, Takahashi T et al. Prognostic factors for patients with colon or rectal carcinoma treated with resection only. Five-year follow-up report. Cancer 1996;78:403-8.
3. Nordlinger B, Guiguet M, Vaillant J, Balladur P, Boudjema K, Bachellier P et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 1996;77:1254-62.
4. Choti MA, Sitzmann JV, Tiburi MF, Sumetchotimetha W, Rangsin R, Schulick RD et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 2002;235:759-66.
5. Scheele J, Stangl R, Altendorf-Hofmann A, Gall FP. Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 1991;110:13-29.
6. Gennari L, Doci R, Bignami P, Bozzetti F. Surgical treatment of hepatic metastases from colorectal cancer. Ann Surg 1986;2003:49-54.
7. Hohenberger P, Schlag P, Schwarz V, Herfarth C. Tumor recurrence and options for further treatment after resection of liver metastases in patients with colorectal cancer. J Surg Oncol 1990;44:245-51.
8. Fong Y, Cohen AM, Fortner JG, Enker WE, Turnbull AD, Coit DG et al. Liver resection for colorectal metastases. J Clin Oncol 1997;15:938-46.
9. Cady B, Jenkins RL, Steele GD Jr, Lewis WD, Stone MD, McDermott WV et al. Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome. Ann Surg 1998;227: 566-71.
10. Steele G Jr. Natural history studies and the evolution of regional treatment modalities for patients with isolated liver metastases from primary colon and rectum carcinoma. Cancer Control 1996;3:34-41.
11. Fortner JG. Recurrence of colorectal cancer after hepatic resection. Am J Surg 1988;155:378-82.
12. Metzger U, Weder W, Rothlin M, Largiader F. Phase II study of intra-arterial fluorouracil and mitomycin-C for liver metastases of colorectal cancer. Recent results. Cancer Res 1991;121:198-204.
13. Howell JD, McArdle CS, Kerr DJ, Buckles J, Ledermann JA, Taylor I et al. A phase II study of regional 2-weekly 5-fluorouracil infusion with intravenous folinic acid in the treatment of colorectal liver metastases. Br J Cancer 1997;76:1390-3.
14. Link KH, Pillasch J, Formentini A, Sunelaitis E, Leder G, Safi F et al. Downstaging by regional chemotherapy of non-resectable isolated colorectal liver metastases. Eur J Surg Oncol 1999;25:381-8.
15. Kemeny MM, Adak S, Gray B, Macdonald JS, Smith T, Lipsitz S et al. Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy - an intergroup study. J Clin Oncol 2002;20:1499-1505.
16. Bismuth H, Adam R, Lévi F, Farabos C, Waechter F, Castaing D et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 1996;224:509-22.
17. Clavien P, Selzner N, Morse M, Selzner M, Paulson E. Downstaging of hepatocellular carcinoma and liver metastases from colorectal cancer by selective intra-arterial chemotherapy. Surgery 2002;131:433-42.
18. Miyanari N, Mori T, Takahashi K, Yasuno M. Evaluation of aggressively treated patients with unresectable multiple liver metastases from colorectal cancer. Dis Colon Rectum 2002;45:1503-9.
19. Meta-Analysis Group in Cancer. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst 1996;88:252-8.
20. Sadahiro S, Suzuki T, Tokunaga N, Tajima T, Makuuchi H, Ohtaki M. Prevention of hepatic artery occlusion during continuous infusion of fluorouracil using liposteroid. Am J Roentgenol 2000:175:1641-2.
21. Sadahiro S, Suzuki T, Ishikawa K, Yasuda S, Tajima T, Makuuchi H et al. Prophylactic hepatic arterial infusion chemotherapy for the prevention of liver metastasis in patients with colon carcinoma. A randomized controlled trial. Cancer 2004:100:590-7.
22. Philippe E, Gal YL. Growth of seventy-eight recurrent mammary cancers, quantitative study. Cancer 1968;21:461-7.
23. Safi F, Bittner R, Roscher R, Schuhmacher K, Gaus W, Beger GH. Regional chemotherapy for hepatic metastases of colorectal carcinoma (continuous intraarterial versus continuous intraarterial/intravenous therapy). Results of a controlled clinical trial. Cancer 1989;64:379-87.
24. Collins VP. Time of occurrence of pulmonary metastasis from carcinoma of colon and rectum. Cancer 1962;15:387-95.
25. Spratt JS, Spratt TL. Rates of growth of pulmonary metastases and host survival. Ann Surg 1964;159:161-71.
26. Fisher B, Wolmark N, Rockette H, Redmond C, Deutsch M, Wickerham DL et al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J Natl Cancer Inst 1988;80:21-9.
27. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Goodman PJ et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990;322:352-8.
28. Wolmark N, Rockette H, Fisher B, Wickerham DL, Redmond C, Fisher ER et al. The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03. J Clin Oncol 1993;11:1879-87.
29. Sadahiro S, Suzuki T, Ishikawa K, Nakamura T, Tanaka Y, Masuda T et al. Recurrence patterns after curative resection of colorectal cancer in patients followed for a minimum of ten years. Hepatogastroenterology 2003;53:1362-6.
30. Hayashi N, Egami H, Kai M, Kurusu Y, Takano S, Ogawa M. No-touch isolation technique reduces intraoperative shedding of tumor cells into the portal vein during resection of colorectal cancer. Surgery 1999;125: 369-74.
31. Miyazono F, Takao S, Natsugoe S, Uchikura K, Kijima F, Aridome K et al. Molecular detection of circulating cancer cells during surgery in patients with biliaty-pancreatic cancer. Am J Surg 1999;177:475-9.
32. Sadahiro S, Suzuki T, Tokunaga N, Yurimoto S, Yasuda S, Tajima T et al. Detection of tumor cells in the portal and peripheral blood of patients with colorectal carcinoma using competitive reverse transcriptase-polymerase chain reaction. Cancer 2001;92:1251-8.